118 related articles for article (PubMed ID: 15857613)
1. Stimulation of neuropeptide Y-mediated calcium responses in human SMS-KAN neuroblastoma cells endogenously expressing Y2 receptors by co-expression of chimeric G proteins.
Dautzenberg FM
Biochem Pharmacol; 2005 May; 69(10):1493-9. PubMed ID: 15857613
[TBL] [Abstract][Full Text] [Related]
2. Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3-(5-benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist.
Dautzenberg FM; Higelin J; Pflieger P; Neidhart W; Guba W
Neuropharmacology; 2005 Jun; 48(7):1043-55. PubMed ID: 15857631
[TBL] [Abstract][Full Text] [Related]
3. Pertussis toxin induces parallel loss of neuropeptide Y Y1 receptor dimers and Gi alpha subunit function in CHO cells.
Parker SL; Parker MS; Sah R; Balasubramaniam A; Sallee FR
Eur J Pharmacol; 2008 Jan; 579(1-3):13-25. PubMed ID: 17967449
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
[TBL] [Abstract][Full Text] [Related]
5. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
Amlal H; Faroqui S; Balasubramaniam A; Sheriff S
Cancer Res; 2006 Apr; 66(7):3706-14. PubMed ID: 16585197
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of the human neuropeptide Y Y2-receptor.
Ingenhoven N; Eckard CP; Gehlert DR; Beck-Sickinger AG
Biochemistry; 1999 May; 38(21):6897-902. PubMed ID: 10346911
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacology of adrenergic alpha(2C) receptors coupled to Ca(2+) signaling through different Galpha proteins.
Kurko D; Bekes Z; Gere A; Baki A; Boros A; Kolok S; Bugovics G; Nagy J; Szombathelyi Z; Ignácz-Szendrei G
Neurochem Int; 2009 Dec; 55(7):467-75. PubMed ID: 19426776
[TBL] [Abstract][Full Text] [Related]
8. Parallel inactivation of Y2 receptor and G-proteins in CHO cells by pertussis toxin.
Parker SL; Parker MS; Sah R; Sallee FR; Balasubramaniam A
Regul Pept; 2007 Mar; 139(1-3):128-35. PubMed ID: 17175038
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
Gehlert DR; Schober DA; Morin M; Berglund MM
Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
[TBL] [Abstract][Full Text] [Related]
10. Regulation of K+ and Ca++ channels by a family of neuropeptide Y receptors.
Sun L; Philipson LH; Miller RJ
J Pharmacol Exp Ther; 1998 Feb; 284(2):625-32. PubMed ID: 9454807
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
Körner M; Reubi JC
J Neuropathol Exp Neurol; 2008 Aug; 67(8):741-9. PubMed ID: 18648328
[TBL] [Abstract][Full Text] [Related]
12. Y2 receptors for neuropeptide Y are coupled to three intracellular signal transduction pathways in a human neuroblastoma cell line.
Shigeri Y; Fujimoto M
J Biol Chem; 1994 Mar; 269(12):8842-8. PubMed ID: 8132619
[TBL] [Abstract][Full Text] [Related]
13. Unaltered neuropeptide Y (NPY)-stimulated [35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice.
Christensen DZ; Olesen MV; Kristiansen H; Mikkelsen JD; Woldbye DP
J Neurosci Res; 2006 Nov; 84(6):1282-91. PubMed ID: 16941487
[TBL] [Abstract][Full Text] [Related]
14. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
15. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
Gehlert DR; Shaw JL
Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a neuronal cell line expressing native human melanin-concentrating hormone receptor 1 (MCHR1).
Fry D; Dayton B; Brodjian S; Ogiela C; Sidorowicz H; Frost LJ; McNally T; Reilly RM; Collins CA
Int J Biochem Cell Biol; 2006; 38(8):1290-9. PubMed ID: 16524757
[TBL] [Abstract][Full Text] [Related]
17. Receptors for neuropeptide Y, gamma-aminobutyric acid and dopamine differentially regulate Ca2+ currents in Xenopus melanotrope cells via the G(i) protein beta/gamma-subunit.
Zhang H; Roubos EW; Jenks BG; Scheenen WJ
Gen Comp Endocrinol; 2006 Jan; 145(2):140-7. PubMed ID: 16214143
[TBL] [Abstract][Full Text] [Related]
18. Cell-type specific calcium signaling by corticotropin-releasing factor type 1 (CRF1) and 2a (CRF2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells.
Dautzenberg FM; Gutknecht E; Van der Linden I; Olivares-Reyes JA; Dürrenberger F; Hauger RL
Biochem Pharmacol; 2004 Nov; 68(9):1833-44. PubMed ID: 15450949
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human cannabinoid CB2 receptor coupled to chimeric Galpha(qi5) and Galpha(qo5) proteins.
Malysz J; Daza AV; Kage K; Grayson GK; Yao BB; Meyer MD; Gopalakrishnan M
Eur J Pharmacol; 2009 Jan; 603(1-3):12-21. PubMed ID: 19071106
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of human neuropeptide Y receptor subtype five specific antagonists using a luciferase reporter gene assay.
Beauverger P; Rodriguez M; Nicolas JP; Audinot V; Lamamy V; Dromaint S; Nagel N; Macia C; Léopold O; Galizzi JP; Caignard DH; Aldana I; Monge A; Chomarat P; Boutin JA
Cell Signal; 2005 Apr; 17(4):489-96. PubMed ID: 15601626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
